Our study also found that FLIPI was a highly significant tool that predicted clinical outcomes with 10‐year OS of 69% in the low risk compared to 28% in the high‐risk group.
← all excerpts
Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy.
1
—
—